Table 3.
Outcome | Surgery | Intervention | Est | SE | p | Estpairwise | SEpairwise | Ppairwise |
---|---|---|---|---|---|---|---|---|
DQI-I | RYGB | Placebo | 23.5 | 4.12 | <0.001 | 6.64 | 4.85 | 0.171 |
Probiotic | 16.9 | 2.55 | <0.001 | |||||
SG | Placebo | 10.1 | 3.14 | 0.001 | −6.02 | 4.95 | 0.224 | |
Probiotic | 16.1 | 3.83 | <0.001 | |||||
DQI-I variety |
RYGB | Placebo | 0.25 | 2.38 | 0.916 | −1.54 | 2.80 | 0.582 |
Probiotic | 1.79 | 1.47 | 0.224 | |||||
SG | Placebo | −2.36 | 1.81 | 0.192 | −0.37 | 2.86 | 0.897 | |
Probiotic | −1.99 | 2.21 | 0.268 | |||||
DQI-I adequacy |
RYGB | Placebo | 10.75 | 1.64 | <0.001 | 3.37 | 1.94 | 0.082 |
Probiotic | 7.39 | 1.02 | <0.001 | |||||
SG | Placebo | 4.98 | 1.26 | <0.001 | −2.06 | 1.99 | 0.300 | |
Probiotic | 7.04 | 1.54 | <0.001 | |||||
DQI-I moderation |
RYGB | Placebo | 7.50 | 2.89 | 0.009 | 2.05 | 3.38 | 0.544 |
Probiotic | 5.45 | 1.75 | 0.002 | |||||
SG | Placebo | 5.38 | 2.02 | 0.008 | −0.28 | 3.18 | 0.929 | |
Probiotic | 5.67 | 2.46 | 0.021 | |||||
DQI-I overall balance |
RYGB | Placebo | 5.00 | 1.09 | <0.001 | 2.08 | 1.27 | 0.103 |
Probiotic | 2.92 | 0.66 | <0.001 | |||||
SG | Placebo | 3.69 | 0.77 | <0.001 | 0.61 | 1.21 | 0.614 | |
Probiotic | 3.08 | 0.94 | <0.001 |
RYGB—Roux-en-Y Gastric Bypass, SG—Sleeve Gastrectomy, DQI-I—diet quality index international, Est—estimate of average marginal effect (AME), SE—standard error, p—p value for testing the significance of AME estimates, Estpairwise, SEpairwise, Ppairwise—estimates of AME, standard error and p value, respectively, for pairwise comparisons between Placebo and Probiotic group (Placebo minus Probiotic).